Victor Villalobos, MD, PhD, Assistant Professor, Director of Sarcoma and T3 (Target-based Therapeutics Team), University of Colorado Denver, presents “Nirogacestat (a gamma secretase inhibitor) in desmoid tumors.”
Dr. Villalobos is a Medical Oncologist specializing in sarcoma and early phase drug development. His primary interest are in the development of novel immunotherapeutic combinations and targeted therapies for the treatment of both soft tissue and bone sarcomas. At his institution they see over 250 new sarcoma cases each year and serve as a regional center of expertise within the Inter-Mountain West.
